Form 4: Bicycle Therapeutics Executive Sells Shares

Michael Hannay, Chief Prod & Supply Chain Officer at Bicycle Therapeutics PLC, reported the sale of 1,761 ordinary shares on July 2nd and July 6th, 2026.

Summary

• Michael Hannay, Chief Prod & Supply Chain Officer of Bicycle Therapeutics PLC, sold a total of 1,761 ordinary shares across two transactions.
• The first transaction on July 2, 2026, involved the sale of 1,506 shares at a weighted average price of $4.27.
• The second transaction on July 6, 2026, involved the sale of 255 shares at a weighted average price of $4.31.
• These sales were conducted to cover statutory tax withholding obligations related to the vesting and settlement of Restricted Stock Units (RSUs).
• Following these transactions, Hannay beneficially owns 94,375 ordinary shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the share sales are attributed to mandatory tax withholding for RSU vesting, rather than a discretionary decision by management to divest.

Negatives

• Executive sale of shares, although explained as tax withholding, can sometimes be perceived negatively by the market.

Future Outlook

No forward-looking statements or guidance are present in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions. While this filing details a sale, the explanation provided (tax withholding for RSU vesting) is a common and often non-discretionary reason for such sales, typically having a neutral to minimal impact on the stock price unless the volume is exceptionally high relative to the executive's holdings or float.

Stakeholder Impact

• Shareholders: The sale is explained as a tax-related event, which typically has a limited impact on shareholder value. However, any insider selling can create short-term market perception shifts.
• Employees: The transaction relates to RSU vesting, which is a standard component of executive compensation.
• Management: The filing confirms the standard process for managing tax liabilities associated with equity compensation.

Key Dates

Keywords

Form 4, Insider Trading, Share Sale, Bicycle Therapeutics, Michael Hannay, RSU Vesting, Tax Withholding